Literature DB >> 19436567

Use of oral miltefosine for cutaneous leishmaniasis in Canadian soldiers returning from Afghanistan.

Yoav Keynan1, Oscar E Larios, Marni C Wiseman, Marie Plourde, Marc Ouellette, Ethan Rubinstein.   

Abstract

Old world cutaneous leishmaniasis (CL) is caused by Leishmania major and Leishmania tropica, and is endemic to several Asian and Middle-Eastern countries where the rates of infection can be substantial. CL is one of the most common vector-transmitted parasitic infections in Afghanistan. Six cases of CL in Canadian soldiers returning from Afghanistan are reported in the present study. Their lesions did not improve with fluconazole therapy, and the organism demonstrated in vitro resistance. Oral miltefosine seemed effective.

Entities:  

Keywords:  Cutaneous leishmaniasis; Leishmaniasis; Phlebotomus

Year:  2008        PMID: 19436567      PMCID: PMC2663468          DOI: 10.1155/2008/802710

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


  16 in total

1.  Treatment of cutaneous leishmaniasis with antimony: intramuscular versus intralesional administration.

Authors:  A M Alkhawajah; E Larbi; Y al-Gindan; A Abahussein; S Jain
Journal:  Ann Trop Med Parasitol       Date:  1997-12

2.  Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial.

Authors:  R Reithinger; M Mohsen; M Wahid; M Bismullah; R J Quinnell; C R Davies; J Kolaczinski; J R David
Journal:  Clin Infect Dis       Date:  2005-03-16       Impact factor: 9.079

3.  Oral miltefosine for Indian visceral leishmaniasis.

Authors:  Shyam Sundar; T K Jha; C P Thakur; Juergen Engel; Herbert Sindermann; Christina Fischer; Klaus Junge; Anthony Bryceson; Jonathan Berman
Journal:  N Engl J Med       Date:  2002-11-28       Impact factor: 91.245

Review 4.  Leishmaniasis.

Authors:  B L Herwaldt
Journal:  Lancet       Date:  1999-10-02       Impact factor: 79.321

5.  A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey.

Authors:  O Ozgoztasi; I Baydar
Journal:  Int J Dermatol       Date:  1997-01       Impact factor: 2.736

6.  Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm.

Authors:  A J Magill; M Grögl; R A Gasser; W Sun; C N Oster
Journal:  N Engl J Med       Date:  1993-05-13       Impact factor: 91.245

7.  Update: Cutaneous leishmaniasis in U.S. military personnel--Southwest/Central Asia, 2002-2004.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2004-04-02       Impact factor: 17.586

8.  Miltefosine for new world cutaneous leishmaniasis.

Authors:  J Soto; B A Arana; J Toledo; N Rizzo; J C Vega; A Diaz; M Luz; P Gutierrez; M Arboleda; J D Berman; K Junge; J Engel; H Sindermann
Journal:  Clin Infect Dis       Date:  2004-04-09       Impact factor: 9.079

9.  Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs.

Authors:  R Hadighi; P Boucher; A Khamesipour; A R Meamar; G Roy; M Ouellette; M Mohebali
Journal:  Parasitol Res       Date:  2007-07-05       Impact factor: 2.289

10.  Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India.

Authors:  Sujit K Bhattacharya; T K Jha; Shyam Sundar; C P Thakur; Juergen Engel; Herbert Sindermann; Klaus Junge; Juntra Karbwang; Anthony D M Bryceson; Jonathan D Berman
Journal:  Clin Infect Dis       Date:  2003-12-18       Impact factor: 9.079

View more
  10 in total

Review 1.  Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis.

Authors:  Begoña Monge-Maillo; Rogelio López-Vélez
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

Review 2.  An update on pharmacotherapy for leishmaniasis.

Authors:  Shyam Sundar; Jaya Chakravarty
Journal:  Expert Opin Pharmacother       Date:  2014-10-25       Impact factor: 3.889

Review 3.  Leishmaniasis: new insights from an old and neglected disease.

Authors:  S Antinori; L Schifanella; M Corbellino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-01       Impact factor: 3.267

4.  A species-specific approach to the use of non-antimony treatments for cutaneous leishmaniasis.

Authors:  Roshan Ramanathan; Kawsar R Talaat; Daniel P Fedorko; Siddhartha Mahanty; Theodore E Nash
Journal:  Am J Trop Med Hyg       Date:  2011-01       Impact factor: 2.345

5.  Case Report: Local Treatment of a Leishmania tropica Infection in a Syrian Child with a Novel Filmogenic Preparation of Pharmaceutical Sodium Chlorite (LeiProtect®).

Authors:  Dirk Debus; Semra Genç; Philipp Kurz; Martin Holzer; Kurt Bauer; Ralph Heimke-Brinck; Martin Baier; Heidi Sebald; Andrea Debus; Christian Bogdan; Kurt-Wilhelm Stahl
Journal:  Am J Trop Med Hyg       Date:  2022-01-10       Impact factor: 3.707

6.  Optimal dosing of miltefosine in children and adults with visceral leishmaniasis.

Authors:  Thomas P C Dorlo; Alwin D R Huitema; Jos H Beijnen; Peter J de Vries
Journal:  Antimicrob Agents Chemother       Date:  2012-05-14       Impact factor: 5.191

7.  Genetic polymorphisms and drug susceptibility in four isolates of Leishmania tropica obtained from Canadian soldiers returning from Afghanistan.

Authors:  Marie Plourde; Adriano Coelho; Yoav Keynan; Oscar E Larios; Momar Ndao; Annie Ruest; Gaétan Roy; Ethan Rubinstein; Marc Ouellette
Journal:  PLoS Negl Trop Dis       Date:  2012-01-17

8.  Dynamics of parasite clearance in cutaneous leishmaniasis patients treated with miltefosine.

Authors:  Thomas P C Dorlo; Pieter P A M van Thiel; Gerard J Schoone; Ymkje Stienstra; Michèle van Vugt; Jos H Beijnen; Peter J de Vries
Journal:  PLoS Negl Trop Dis       Date:  2011-12-13

9.  Effectiveness of miltefosine in cutaneous leishmaniasis caused by Leishmania tropica in Pakistan after antimonial treatment failure or contraindications to first line therapy-A retrospective analysis.

Authors:  Suzette Kämink; Boota Masih; Noor Ali; Aman Ullah; Syed Juma Khan; Shakil Ashraf; Tetyana Pylypenko; Martin P Grobusch; Jena Fernhout; Margriet den Boer; Koert Ritmeijer
Journal:  PLoS Negl Trop Dis       Date:  2021-01-28

10.  Rapid healing of cutaneous leishmaniasis by high-frequency electrocauterization and hydrogel wound care with or without DAC N-055: a randomized controlled phase IIa trial in Kabul.

Authors:  Ahmad Fawad Jebran; Ulrike Schleicher; Reto Steiner; Pia Wentker; Farouq Mahfuz; Hans-Christian Stahl; Faquir Mohammad Amin; Christian Bogdan; Kurt-Wilhelm Stahl
Journal:  PLoS Negl Trop Dis       Date:  2014-02-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.